Ahead of Pharma Conclave 2025, Odisha Offers Mega Incentives to Build Pharma-Med-Tech Hub

To support this transition, the government has established the Odisha Pharmaceutical Development Cell (OPDC) to coordinate policy implementation, assist investors and develop a structured ecosystem for pharmaceutical and medical-devices manufacturing. The state is also working toward creating sector-specific SEZs and building additional industrial infrastructure dedicated to the life-sciences sector.

Momentum has begun to build, with nine pharmaceutical and biotechnology companies submitting investment intents worth ₹4,349 crore for setting up manufacturing plants, biotech units and healthcare facilities across Odisha. According to state officials, these developments are aligned with the larger Viksit Odisha 2036 roadmap that seeks to position the state as a competitive industrial and innovation-driven economy.

Investment promotion activities are being led by IPICOL (Industrial Promotion & Investment Corporation of Odisha Ltd.), which has intensified outreach to industry players, highlighting the incentives, infrastructure benefits and simplified approval processes under the new policy. The government aims to convert these investment proposals into firm commitments, strengthening Odisha’s standing as an emerging pharma-med-tech hub, reports The Hindu BusinessLine.